Clinical Trials in Pittsburgh

Showing 10401-10420 of 16,007 trials

LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients

NCT02631772

The predominant remaining questions for post-transplant treatment of Hepatitis C virus (HCV) in the DAA (direct acting anti-virals) era are whether a ribavirin-free regimen is possible and whether pre-emptive treatment is now a potential option to prevent long-term damage to the allograft. Our aim is to provide answers to these primary questions with our multicenter, prospective, randomized, open-label intent-to-treat phase IV study

Hepatitis C

Medical University of South Carolina32 participantsStarted Jun 2016

Washington D.C., District of Columbia, United States • Cleveland, Ohio, United States • Pittsburgh, Pennsylvania, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

NCT02780167

Study B7451006 is a Phase 2b POC study which is planned to assess four PF 04965842 once daily (QD) doses (10, 30, 100, 200 mg) relative to placebo over 12 weeks to characterize the efficacy and safety of PF 04965842 in subjects with moderate to severe AD. The objectives of the study are to demonstrate the efficacy of PF 04965842 by showing improvement in disease severity in patients with moderate to severe AD as measured by the Investigator's Global Assessment (IGA) and Eczema Area and Severity Index (EASI) scores, and safety to support further clinical development of PF 04965842.

Atopic Dermatitis

Pfizer269 participantsStarted Apr 2016

Birmingham, Alabama, United States • Encinitas, California, United States • Pasadena, California, United States +61 more locations

LIVE-C-Free: Early and Late Treatment of Hepatitis C With Sofosbuvir/Ledipasvir in Liver Transplant Recipients

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

Find Trials by Condition in Pittsburgh

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Vitabreath Pilot in Chronic Obstructive Pulmonary Disease (COPD) Patients

A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump

A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DM

BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

Operative Versus Nonoperative Treatment of Humeral Shaft Fractures: A Prospective Cohort Comparison Study

Sodium Management in Acute Neurological Injury

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

Fenzian Asthma Multicenter Outcomes Study

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

Cardiac Output Measurement by TEE

A Study for Patients With Acute Leukemia

Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder